Literature DB >> 33571201

DEXOM: Diversity-based enumeration of optimal context-specific metabolic networks.

Pablo Rodríguez-Mier1, Nathalie Poupin1, Carlo de Blasio2,3, Laurent Le Cam2,3, Fabien Jourdan1.   

Abstract

The correct identification of metabolic activity in tissues or cells under different conditions can be extremely elusive due to mechanisms such as post-transcriptional modification of enzymes or different rates in protein degradation, making difficult to perform predictions on the basis of gene expression alone. Context-specific metabolic network reconstruction can overcome some of these limitations by leveraging the integration of multi-omics data into genome-scale metabolic networks (GSMN). Using the experimental information, context-specific models are reconstructed by extracting from the generic GSMN the sub-network most consistent with the data, subject to biochemical constraints. One advantage is that these context-specific models have more predictive power since they are tailored to the specific tissue, cell or condition, containing only the reactions predicted to be active in such context. However, an important limitation is that there are usually many different sub-networks that optimally fit the experimental data. This set of optimal networks represent alternative explanations of the possible metabolic state. Ignoring the set of possible solutions reduces the ability to obtain relevant information about the metabolism and may bias the interpretation of the true metabolic states. In this work we formalize the problem of enumerating optimal metabolic networks and we introduce DEXOM, an unified approach for diversity-based enumeration of context-specific metabolic networks. We developed different strategies for this purpose and we performed an exhaustive analysis using simulated and real data. In order to analyze the extent to which these results are biologically meaningful, we used the alternative solutions obtained with the different methods to measure: 1) the improvement of in silico predictions of essential genes in Saccharomyces cerevisiae using ensembles of metabolic network; and 2) the detection of alternative enriched pathways in different human cancer cell lines. We also provide DEXOM as an open-source library compatible with COBRA Toolbox 3.0, available at https://github.com/MetExplore/dexom.

Entities:  

Mesh:

Year:  2021        PMID: 33571201      PMCID: PMC7904180          DOI: 10.1371/journal.pcbi.1008730

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  34 in total

1.  Large-Scale Modeling Approach Reveals Functional Metabolic Shifts during Hepatic Differentiation.

Authors:  Nathalie Poupin; Anne Corlu; Nicolas J Cabaton; Hélène Dubois-Pot-Schneider; Cécile Canlet; Elodie Person; Sandrine Bruel; Clément Frainay; Florence Vinson; Florence Maurier; Fabrice Morel; Marie-Anne Robin; Bernard Fromenty; Daniel Zalko; Fabien Jourdan
Journal:  J Proteome Res       Date:  2018-11-19       Impact factor: 4.466

Review 2.  Metabolic control analysis in drug discovery and disease.

Authors:  Marta Cascante; Laszlo G Boros; Begoña Comin-Anduix; Pedro de Atauri; Josep J Centelles; Paul W-N Lee
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

Review 3.  Cancer cell metabolism as new targets for novel designed therapies.

Authors:  Igor Marín de Mas; Esther Aguilar; Anusha Jayaraman; Ibrahim H Polat; Alfonso Martín-Bernabé; Rohit Bharat; Carles Foguet; Enric Milà; Balázs Papp; Josep J Centelles; Marta Cascante
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

4.  Network-based prediction of human tissue-specific metabolism.

Authors:  Tomer Shlomi; Moran N Cabili; Markus J Herrgård; Bernhard Ø Palsson; Eytan Ruppin
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

5.  Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0.

Authors:  Laurent Heirendt; Sylvain Arreckx; Thomas Pfau; Sebastián N Mendoza; Anne Richelle; Almut Heinken; Hulda S Haraldsdóttir; Jacek Wachowiak; Sarah M Keating; Vanja Vlasov; Stefania Magnusdóttir; Chiam Yu Ng; German Preciat; Alise Žagare; Siu H J Chan; Maike K Aurich; Catherine M Clancy; Jennifer Modamio; John T Sauls; Alberto Noronha; Aarash Bordbar; Benjamin Cousins; Diana C El Assal; Luis V Valcarcel; Iñigo Apaolaza; Susan Ghaderi; Masoud Ahookhosh; Marouen Ben Guebila; Andrejs Kostromins; Nicolas Sompairac; Hoai M Le; Ding Ma; Yuekai Sun; Lin Wang; James T Yurkovich; Miguel A P Oliveira; Phan T Vuong; Lemmer P El Assal; Inna Kuperstein; Andrei Zinovyev; H Scott Hinton; William A Bryant; Francisco J Aragón Artacho; Francisco J Planes; Egils Stalidzans; Alejandro Maass; Santosh Vempala; Michael Hucka; Michael A Saunders; Costas D Maranas; Nathan E Lewis; Thomas Sauter; Bernhard Ø Palsson; Ines Thiele; Ronan M T Fleming
Journal:  Nat Protoc       Date:  2019-03       Impact factor: 13.491

6.  Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE.

Authors:  Yuliang Wang; James A Eddy; Nathan D Price
Journal:  BMC Syst Biol       Date:  2012-12-13

7.  Predicting selective drug targets in cancer through metabolic networks.

Authors:  Ori Folger; Livnat Jerby; Christian Frezza; Eyal Gottlieb; Eytan Ruppin; Tomer Shlomi
Journal:  Mol Syst Biol       Date:  2011-06-21       Impact factor: 11.429

8.  Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT.

Authors:  Rasmus Agren; Sergio Bordel; Adil Mardinoglu; Natapol Pornputtapong; Intawat Nookaew; Jens Nielsen
Journal:  PLoS Comput Biol       Date:  2012-05-17       Impact factor: 4.475

Review 9.  Targeting cellular metabolism to improve cancer therapeutics.

Authors:  Y Zhao; E B Butler; M Tan
Journal:  Cell Death Dis       Date:  2013-03-07       Impact factor: 8.469

10.  StanDep: Capturing transcriptomic variability improves context-specific metabolic models.

Authors:  Chintan J Joshi; Song-Min Schinn; Anne Richelle; Isaac Shamie; Eyleen J O'Rourke; Nathan E Lewis
Journal:  PLoS Comput Biol       Date:  2020-05-12       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.